The presenters of the video are AMCP Executive Director Judy Cahill, Director of Government Relations Bill AMCP Hermelin and Deputy Director of Government Relations GCAP Lauren Fuller. To access the video, click the following:Part 1 explains the provisions relating to Part D drug benefit, including the negotiations of the government of the prices of drugs, therapeutic classes, and protected forms of drug therapy management. Part 2 explains the other relevant provisions of Managed Care Pharmacy, including comparative effectiveness research, the public insurance option, the transparency of the insurance market, monitoring of biological products and generic drugs. The programs also provide GCAP positions on these issues.
GCAP has posted a video in two parts, explaining the provisions in the care of House and Senate reform bills that would affect the practice of pharmacy in managed care.